Denali Therapeutics Inc (DNLI) Insider Trades

DNLI Insider Trading Activity

Track insider trading transactions for Denali Therapeutics Inc (DNLI). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

Current stock price: $18.62. Market cap: $2.95B. This page displays the most recent insider transactions for DNLI, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Denali Therapeutics Inc's investment outlook.